Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences

Sagimet Biosciences (SGMT) will participate in two investor conferences in September 2026 in New York.

Rhea-AI Summary

Sagimet Biosciences (SGMT) will participate in two investor conferences in September 2026 in New York. Management joins the Cantor 2026 Global Healthcare Conference on September 9, 2026, including a fireside chat at 1:35 p.m. ET, and the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. A webcast of the fireside chat and a 90-day replay will be accessible via the Investors & Media section of the company’s website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences.

• Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat at 1.35pm ET (link here).
• H.C. Wainwright 28^th Annual Global Investment Conference in New York, NY on Monday, September 14, 2026.
  
  

The fireside chat will be available in the Investors & Media section of Sagimet’s website at www.sagimet.com, with an archived replay available for 90 days following the live event.

About Sagimet Biosciences

Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional metabolic and fibrotic pathways in conditions resulting from the overproduction of the fatty acid, palmitate. FASN is a regulator of lipid synthesis, a key pathway implicated in multiple diseases, such as acne, MASH and certain FASN-dependent tumor types. For additional information about Sagimet, please visit www.sagimet.com.

Investor Contact:
Joyce Allaire 
LifeSci Advisors 
JAllaire@LifeSciAdvisors.com

Media Contact:
Maggie Whitney
LifeSci Communications
mwhitney@lifescicomms.com

FAQ

When will Sagimet Biosciences (SGMT) present at the Cantor 2026 Global Healthcare Conference?

Sagimet Biosciences will participate in the Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat scheduled for 1:35 p.m. ET.

What is the date of Sagimet Biosciences (SGMT) presentation at the H.C. Wainwright 28th Annual Global Investment Conference?

Sagimet Biosciences is scheduled to participate in the H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on Monday, September 14, 2026.

How can investors access the Sagimet Biosciences (SGMT) fireside chat webcast?

The fireside chat webcast will be available in the Investors & Media section of Sagimet Biosciences’ website at www.sagimet.com.

Will a replay of the Sagimet Biosciences (SGMT) conference fireside chat be available?

Yes. An archived replay of the Sagimet Biosciences fireside chat will be available on the company’s website for 90 days following the live event.